A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Clinical trial NCT00823979 · TERMINATED

Trial details

NCT number

NCT00823979

Sponsor

Pfizer

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-03-25

Primary completion

2012-10-18

Enrollment

105

View on ClinicalTrials.gov